Page 3 - Courses Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Courses program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Courses Program Today - Breaking & Trending Today

Πανελλαδικές: Οσα πρέπει να γνωρίζουν οι υποψήφιοι για τα Ειδικά Μαθήματα -Πρόγραμμα, εξεταστικά κέντρα, οδηγίες | ΠΑΝΕΛΛΗΝΙΕΣ

Πανελλαδικές: Οσα πρέπει να γνωρίζουν οι υποψήφιοι για τα Ειδικά Μαθήματα -Πρόγραμμα, εξεταστικά κέντρα, οδηγίες | ΠΑΝΕΛΛΗΝΙΕΣ
iefimerida.gr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from iefimerida.gr Daily Mail and Mail on Sunday newspapers.

Perifereia Thessalias , Perifereia Kentrikis Makedonias , Palaio Faliro , Perifereia Attikis , Perifereia Peloponnisou , Central Macedonia , Perifereia Kritis , Western Greece , Perifereia Dytikis Elladas , Nea Ionia , Nea Smyrni , Perifereia Stereas Elladas , North Aegean , Perifereia Voreiou Aigaiou , Agios Dimitrios , Perifereia Ipeirou , South Aegean , Perifereia Notiou Aigaiou , Central Greece , Constantine Karamanlis , High School Going Green , High School Experiment , High School New Smyrna , High School Kalamaria , Building Of Ministry Education , Centers Applicantsa Disability ,

Northwell Health and Cold Spring Harbor Laboratory open virtual COVID-19 clinical trial for non-hospitalized patients


Northwell Health and Cold Spring Harbor Laboratory open virtual COVID-19 clinical trial for non-hospitalized patients
By
Staff
2 months ago
An outpatient, digital, randomized clinical trial will look at the safety and efficacy of famotidine (PEPCID) to treat mild to moderate Covid-19
MANHASSET, N.Y.–(BUSINESS WIRE)–The Feinstein Institutes for Medical Research and Cold Spring Harbor Laboratory (CSHL) are recruiting patients in a fully virtual, in-home, randomized, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of famotidine, or PEPCID, for the outpatient treatment of the novel coronavirus disease 2019 (COVID-19) in adults. Sold over-the-counter as PEPCID, famotidine is a histamine 2 blocker used to decrease stomach acid and this clinical trial will assess its use as a COVID-19 therapy. ....

New York , United States , Pershing Square , Cold Spring Harbor Laboratory , Kevinj Tracey , Tobias Janowitz , Northwell Home Lab , Northwell Health Is New York , National Cancer Institute , Northwell Health , Northwell Health Physician Partners , Pershing Square Foundation , Meetings Courses Program , Hofstra Northwell School Of Nursing , Feinstein Institutes For Medical Research , Feinstein Institutes , Medical Research , Home Lab , Trial Unit , Fast Grant , New York State , Barbara Zucker School , Hofstra Northwell School , Physician Assistant , Nobel Prize , Courses Program ,